Drug Manufacturers - Specialty & Generic
Compare Stocks
4 / 10Stock Comparison
PAHC vs TSN vs HRL vs PPC
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural Farm Products
Packaged Foods
Packaged Foods
PAHC vs TSN vs HRL vs PPC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Agricultural Farm Products | Packaged Foods | Packaged Foods |
| Market Cap | $1.75B | $24.18B | $11.41B | $7.23B |
| Revenue (TTM) | $1.46B | $55.71B | $12.14B | $18.57B |
| Net Income (TTM) | $92M | $453M | $489M | $888M |
| Gross Margin | 31.9% | 6.6% | 15.5% | 11.6% |
| Operating Margin | 11.6% | 2.3% | 6.0% | 7.4% |
| Forward P/E | 14.2x | 17.5x | 14.1x | 8.1x |
| Total Debt | $762M | $8.83B | $2.86B | $3.35B |
| Cash & Equiv. | $68M | $1.23B | $671M | $640M |
PAHC vs TSN vs HRL vs PPC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Phibro Animal Healt… (PAHC) | 100 | 164.7 | +64.7% |
| Tyson Foods, Inc. (TSN) | 100 | 110.6 | +10.6% |
| Hormel Foods Corpor… (HRL) | 100 | 42.5 | -57.5% |
| Pilgrim's Pride Cor… (PPC) | 100 | 147.1 | +47.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PAHC vs TSN vs HRL vs PPC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PAHC carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 27.4%, EPS growth 18.8%, 3Y rev CAGR 11.2%
- 128.6% 10Y total return vs PPC's 52.1%
- 27.4% revenue growth vs HRL's 1.6%
- 6.3% margin vs TSN's 0.8%
TSN lags the leaders in this set but could rank higher in a more targeted comparison.
HRL is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.15, Low D/E 36.1%, current ratio 2.47x
- 5.5% yield, 34-year raise streak, vs PPC's 27.5%
PPC is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.
- Dividend streak 1 yrs, beta 0.02, yield 27.5%
- PEG 0.13 vs PAHC's 1.90
- Beta 0.02, yield 27.5%, current ratio 1.47x
- Lower P/E (8.1x vs 14.1x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 27.4% revenue growth vs HRL's 1.6% | |
| Value | Lower P/E (8.1x vs 14.1x) | |
| Quality / Margins | 6.3% margin vs TSN's 0.8% | |
| Stability / Safety | Beta 0.02 vs PAHC's 1.38, lower leverage | |
| Dividends | 5.5% yield, 34-year raise streak, vs PPC's 27.5% | |
| Momentum (1Y) | +125.1% vs PPC's -30.5% | |
| Efficiency (ROA) | 8.7% ROA vs TSN's 1.3%, ROIC 20.0% vs 4.1% |
PAHC vs TSN vs HRL vs PPC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PAHC vs TSN vs HRL vs PPC — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PAHC leads in 2 of 6 categories
PPC leads 2 • TSN leads 0 • HRL leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
PAHC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TSN is the larger business by revenue, generating $55.7B annually — 38.0x PAHC's $1.5B. PAHC is the more profitable business, keeping 6.3% of every revenue dollar as net income compared to TSN's 0.8%. On growth, PAHC holds the edge at +20.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1.5B | $55.7B | $12.1B | $18.6B |
| EBITDAEarnings before interest/tax | $220M | $2.7B | $932M | $1.8B |
| Net IncomeAfter-tax profit | $92M | $453M | $489M | $888M |
| Free Cash FlowCash after capex | $47M | $1.2B | $578M | $773M |
| Gross MarginGross profit ÷ Revenue | +31.9% | +6.6% | +15.5% | +11.6% |
| Operating MarginEBIT ÷ Revenue | +11.6% | +2.3% | +6.0% | +7.4% |
| Net MarginNet income ÷ Revenue | +6.3% | +0.8% | +4.0% | +4.8% |
| FCF MarginFCF ÷ Revenue | +3.2% | +2.2% | +4.8% | +4.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +20.9% | +4.4% | +1.3% | +1.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +7.4% | +36.1% | +6.5% | -65.3% |
Valuation Metrics
PPC leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 6.7x trailing earnings, PPC trades at a 87% valuation discount to TSN's 49.9x P/E. Adjusting for growth (PEG ratio), PPC offers better value at 0.11x vs PAHC's 4.85x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.7B | $24.2B | $11.4B | $7.2B |
| Enterprise ValueMkt cap + debt − cash | $2.4B | $31.8B | $13.6B | $9.9B |
| Trailing P/EPrice ÷ TTM EPS | 36.27x | 49.95x | 23.84x | 6.70x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.23x | 17.46x | 14.13x | 8.05x |
| PEG RatioP/E ÷ EPS growth rate | 4.85x | — | — | 0.11x |
| EV / EBITDAEnterprise value multiple | 15.65x | 11.34x | 13.84x | 4.81x |
| Price / SalesMarket cap ÷ Revenue | 1.35x | 0.44x | 0.94x | 0.39x |
| Price / BookPrice ÷ Book value/share | 6.15x | 1.30x | 1.44x | 1.96x |
| Price / FCFMarket cap ÷ FCF | 41.82x | 20.55x | 21.36x | 10.95x |
Profitability & Efficiency
PPC leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
PAHC delivers a 30.8% return on equity — every $100 of shareholder capital generates $31 in annual profit, vs $2 for TSN. HRL carries lower financial leverage with a 0.36x debt-to-equity ratio, signaling a more conservative balance sheet compared to PAHC's 2.67x. On the Piotroski fundamental quality scale (0–9), TSN scores 6/9 vs PPC's 5/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +30.8% | +2.5% | +4.3% | +24.1% |
| ROA (TTM)Return on assets | +6.7% | +1.3% | +3.7% | +8.7% |
| ROICReturn on invested capital | +9.8% | +4.1% | +5.3% | +20.0% |
| ROCEReturn on capital employed | +12.0% | +4.6% | +6.0% | +20.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 5 | 5 |
| Debt / EquityFinancial leverage | 2.67x | 0.48x | 0.36x | 0.91x |
| Net DebtTotal debt minus cash | $694M | $7.6B | $2.2B | $2.7B |
| Cash & Equiv.Liquid assets | $68M | $1.2B | $671M | $640M |
| Total DebtShort + long-term debt | $762M | $8.8B | $2.9B | $3.4B |
| Interest CoverageEBIT ÷ Interest expense | 3.64x | 2.73x | 6.44x | 8.87x |
Total Returns (Dividends Reinvested)
PAHC leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PAHC five years ago would be worth $16,597 today (with dividends reinvested), compared to $5,569 for HRL. Over the past 12 months, PAHC leads with a +125.1% total return vs PPC's -30.5%. The 3-year compound annual growth rate (CAGR) favors PAHC at 45.9% vs HRL's -15.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +16.0% | +17.9% | -8.8% | -23.8% |
| 1-Year ReturnPast 12 months | +125.1% | +26.8% | -24.7% | -30.5% |
| 3-Year ReturnCumulative with dividends | +210.4% | +45.6% | -40.5% | +71.1% |
| 5-Year ReturnCumulative with dividends | +66.0% | -1.6% | -44.3% | +60.5% |
| 10-Year ReturnCumulative with dividends | +128.6% | +23.1% | -23.9% | +52.1% |
| CAGR (3Y)Annualised 3-year return | +45.9% | +13.3% | -15.9% | +19.6% |
Risk & Volatility
Evenly matched — TSN and PPC each lead in 1 of 2 comparable metrics.
Risk & Volatility
PPC is the less volatile stock with a 0.02 beta — it tends to amplify market swings less than PAHC's 1.38 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TSN currently trades 97.8% from its 52-week high vs PPC's 59.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.38x | 0.33x | 0.15x | 0.02x |
| 52-Week HighHighest price in past year | $60.08 | $69.48 | $31.86 | $51.45 |
| 52-Week LowLowest price in past year | $19.00 | $50.56 | $20.32 | $30.22 |
| % of 52W HighCurrent price vs 52-week peak | +71.8% | +97.8% | +65.1% | +59.1% |
| RSI (14)Momentum oscillator 0–100 | 60.3 | 64.5 | 39.5 | 35.9 |
| Avg Volume (50D)Average daily shares traded | 302K | 2.7M | 4.2M | 1.1M |
Analyst Outlook
Evenly matched — HRL and PPC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PAHC as "Buy", TSN as "Buy", HRL as "Hold", PPC as "Hold". Consensus price targets imply 51.3% upside for PPC (target: $46) vs 3.4% for TSN (target: $70). For income investors, PPC offers the higher dividend yield at 27.51% vs PAHC's 1.11%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $49.00 | $70.25 | $27.25 | $46.00 |
| # AnalystsCovering analysts | 13 | 30 | 29 | 21 |
| Dividend YieldAnnual dividend ÷ price | +1.1% | +2.9% | +5.5% | +27.5% |
| Dividend StreakConsecutive years of raises | 0 | 13 | 34 | 1 |
| Dividend / ShareAnnual DPS | $0.48 | $2.00 | $1.15 | $8.36 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.8% | 0.0% | 0.0% |
PAHC leads in 2 of 6 categories (Income & Cash Flow, Total Returns). PPC leads in 2 (Valuation Metrics, Profitability & Efficiency). 2 tied.
PAHC vs TSN vs HRL vs PPC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PAHC or TSN or HRL or PPC a better buy right now?
For growth investors, Phibro Animal Health Corporation (PAHC) is the stronger pick with 27.
4% revenue growth year-over-year, versus 1. 6% for Hormel Foods Corporation (HRL). Pilgrim's Pride Corporation (PPC) offers the better valuation at 6. 7x trailing P/E (8. 1x forward), making it the more compelling value choice. Analysts rate Phibro Animal Health Corporation (PAHC) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PAHC or TSN or HRL or PPC?
On trailing P/E, Pilgrim's Pride Corporation (PPC) is the cheapest at 6.
7x versus Tyson Foods, Inc. at 49. 9x. On forward P/E, Pilgrim's Pride Corporation is actually cheaper at 8. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Pilgrim's Pride Corporation wins at 0. 13x versus Phibro Animal Health Corporation's 1. 90x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — PAHC or TSN or HRL or PPC?
Over the past 5 years, Phibro Animal Health Corporation (PAHC) delivered a total return of +66.
0%, compared to -44. 3% for Hormel Foods Corporation (HRL). Over 10 years, the gap is even starker: PAHC returned +128. 6% versus HRL's -23. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PAHC or TSN or HRL or PPC?
By beta (market sensitivity over 5 years), Pilgrim's Pride Corporation (PPC) is the lower-risk stock at 0.
02β versus Phibro Animal Health Corporation's 1. 38β — meaning PAHC is approximately 5552% more volatile than PPC relative to the S&P 500. On balance sheet safety, Hormel Foods Corporation (HRL) carries a lower debt/equity ratio of 36% versus 3% for Phibro Animal Health Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — PAHC or TSN or HRL or PPC?
By revenue growth (latest reported year), Phibro Animal Health Corporation (PAHC) is pulling ahead at 27.
4% versus 1. 6% for Hormel Foods Corporation (HRL). On earnings-per-share growth, the picture is similar: Phibro Animal Health Corporation grew EPS 1883% year-over-year, compared to -40. 8% for Hormel Foods Corporation. Over a 3-year CAGR, PAHC leads at 11. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PAHC or TSN or HRL or PPC?
Pilgrim's Pride Corporation (PPC) is the more profitable company, earning 5.
9% net margin versus 0. 9% for Tyson Foods, Inc. — meaning it keeps 5. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PPC leads at 8. 7% versus 2. 6% for TSN. At the gross margin level — before operating expenses — PAHC leads at 30. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PAHC or TSN or HRL or PPC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Pilgrim's Pride Corporation (PPC) is the more undervalued stock at a PEG of 0. 13x versus Phibro Animal Health Corporation's 1. 90x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Pilgrim's Pride Corporation (PPC) trades at 8. 1x forward P/E versus 17. 5x for Tyson Foods, Inc. — 9. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PPC: 51. 3% to $46. 00.
08Which pays a better dividend — PAHC or TSN or HRL or PPC?
All stocks in this comparison pay dividends.
Pilgrim's Pride Corporation (PPC) offers the highest yield at 27. 5%, versus 1. 1% for Phibro Animal Health Corporation (PAHC).
09Is PAHC or TSN or HRL or PPC better for a retirement portfolio?
For long-horizon retirement investors, Pilgrim's Pride Corporation (PPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
02), 27. 5% yield). Both have compounded well over 10 years (PPC: +52. 1%, PAHC: +128. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PAHC and TSN and HRL and PPC?
These companies operate in different sectors (PAHC (Healthcare) and TSN (Consumer Defensive) and HRL (Consumer Defensive) and PPC (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: PAHC is a small-cap high-growth stock; TSN is a mid-cap quality compounder stock; HRL is a mid-cap income-oriented stock; PPC is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.